JP2016531105A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016531105A5 JP2016531105A5 JP2016527071A JP2016527071A JP2016531105A5 JP 2016531105 A5 JP2016531105 A5 JP 2016531105A5 JP 2016527071 A JP2016527071 A JP 2016527071A JP 2016527071 A JP2016527071 A JP 2016527071A JP 2016531105 A5 JP2016531105 A5 JP 2016531105A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- disease
- syndrome
- pharmaceutical composition
- inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361847455P | 2013-07-17 | 2013-07-17 | |
| US61/847,455 | 2013-07-17 | ||
| PCT/US2014/046839 WO2015009820A2 (en) | 2013-07-17 | 2014-07-16 | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019019259A Division JP2019112406A (ja) | 2013-07-17 | 2019-02-06 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016531105A JP2016531105A (ja) | 2016-10-06 |
| JP2016531105A5 true JP2016531105A5 (https=) | 2017-08-24 |
| JP6479789B2 JP6479789B2 (ja) | 2019-03-13 |
Family
ID=52346836
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016527071A Expired - Fee Related JP6479789B2 (ja) | 2013-07-17 | 2014-07-16 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2019019259A Pending JP2019112406A (ja) | 2013-07-17 | 2019-02-06 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2021031378A Pending JP2021090447A (ja) | 2013-07-17 | 2021-03-01 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019019259A Pending JP2019112406A (ja) | 2013-07-17 | 2019-02-06 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2021031378A Pending JP2021090447A (ja) | 2013-07-17 | 2021-03-01 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20160168199A1 (https=) |
| EP (1) | EP3021863A4 (https=) |
| JP (3) | JP6479789B2 (https=) |
| KR (1) | KR20160052537A (https=) |
| CN (1) | CN105517561A (https=) |
| AU (2) | AU2014290116A1 (https=) |
| CA (1) | CA2918223A1 (https=) |
| HK (1) | HK1223298A1 (https=) |
| IL (1) | IL243551A0 (https=) |
| MX (1) | MX2016000448A (https=) |
| SG (2) | SG10201809099PA (https=) |
| WO (1) | WO2015009820A2 (https=) |
| ZA (1) | ZA201600362B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8962015B2 (en) | 2007-09-28 | 2015-02-24 | Sdg, Inc. | Orally bioavailable lipid-based constructs |
| JP2019523633A (ja) | 2016-04-29 | 2019-08-29 | アライム ファーマシューティカルズ，インコーポレーテッド | 組織の損傷に関連した疾患及び障害を予防及び治療する組織保護ペプチド |
| KR102167641B1 (ko) | 2018-08-27 | 2020-10-19 | 주식회사 사이루스 | 에리스로포이에틴 유래 펩티드를 함유하는 세포증식 촉진용 조성물 |
| MX2021002761A (es) | 2018-09-10 | 2021-05-31 | Cold Spring Harbor Laboratory | Metodos para tratar la pancreatitis. |
| US12377112B2 (en) * | 2019-04-17 | 2025-08-05 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
| DE102019215585B4 (de) * | 2019-10-10 | 2022-02-17 | KCM Egészségügyi és Tudományos Korlátolt Felelösségü Társaság | Verfahren zur prävention von strahlenschäden in humanen drüsen |
| CA3170057A1 (en) | 2020-02-06 | 2021-09-10 | Austin Star Detonator Company | Integrated detonator sensors |
| DE102022112056A1 (de) | 2021-05-28 | 2022-12-01 | Shimano Inc. | Komponente für ein mit menschenkraft angetriebenes fahrzeug und elektrisches system für ein mit menschenkraft angetriebenes fahrzeug |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0715633A4 (en) * | 1993-07-28 | 1997-11-19 | Medvet Science Pty Ltd | ANTAGONISTS OF THE HEMOPOIETIC GROWTH FACTOR |
| IL124015A0 (en) * | 1998-04-08 | 1999-01-26 | Yeda Res & Dev | Pharmaceutical compositions comprising a protein |
| CN1318084C (zh) * | 2000-05-26 | 2007-05-30 | 奥索-麦克尼尔药品公司 | 神经保护肽 |
| US20040063917A1 (en) * | 2001-02-06 | 2004-04-01 | Carr Francis J. | Modified erythropoietin (epo) with reduced immunogenicity |
| PL372862A1 (en) * | 2002-08-09 | 2005-08-08 | Merck Patent Gmbh | T-cell epitopes in erythropoietin |
| US7718363B2 (en) * | 2003-04-25 | 2010-05-18 | The Kenneth S. Warren Institute, Inc. | Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds |
| SI2540309T1 (en) * | 2005-08-05 | 2018-04-30 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and their uses |
| WO2008065372A2 (en) * | 2006-11-28 | 2008-06-05 | Nautilus Biotech, S.A. | Modified erythropoietin polypeptides and uses thereof for treatment |
| ES2386495T3 (es) * | 2007-11-29 | 2012-08-21 | Molecular Health Gmbh | siARN específico de EPH-B4 para reducir el crecimiento de células neoplásicas inducidas por EPO durante el tratamiento de anemia en pacientes con cáncer, receptor de eritropoyetina protector de tejido (NEPOR) y métodos de uso |
| KR20200075044A (ko) * | 2008-01-22 | 2020-06-25 | 아라임 파마슈티칼즈, 인크. | 조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체 |
| WO2011022056A2 (en) * | 2009-08-18 | 2011-02-24 | Medical College Of Georgia Research Institute, Inc. | PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF |
-
2014
- 2014-07-16 CA CA2918223A patent/CA2918223A1/en not_active Abandoned
- 2014-07-16 WO PCT/US2014/046839 patent/WO2015009820A2/en not_active Ceased
- 2014-07-16 SG SG10201809099PA patent/SG10201809099PA/en unknown
- 2014-07-16 US US14/905,754 patent/US20160168199A1/en not_active Abandoned
- 2014-07-16 EP EP14825674.6A patent/EP3021863A4/en not_active Withdrawn
- 2014-07-16 AU AU2014290116A patent/AU2014290116A1/en not_active Abandoned
- 2014-07-16 MX MX2016000448A patent/MX2016000448A/es unknown
- 2014-07-16 CN CN201480049424.5A patent/CN105517561A/zh active Pending
- 2014-07-16 HK HK16111663.5A patent/HK1223298A1/zh unknown
- 2014-07-16 KR KR1020167003632A patent/KR20160052537A/ko not_active Ceased
- 2014-07-16 SG SG11201600294QA patent/SG11201600294QA/en unknown
- 2014-07-16 JP JP2016527071A patent/JP6479789B2/ja not_active Expired - Fee Related
-
2016
- 2016-01-11 IL IL243551A patent/IL243551A0/en unknown
- 2016-01-15 ZA ZA2016/00362A patent/ZA201600362B/en unknown
-
2019
- 2019-02-06 JP JP2019019259A patent/JP2019112406A/ja active Pending
-
2020
- 2020-01-17 AU AU2020200352A patent/AU2020200352A1/en not_active Abandoned
- 2020-05-19 US US16/878,318 patent/US20210107942A1/en not_active Abandoned
-
2021
- 2021-03-01 JP JP2021031378A patent/JP2021090447A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016531105A5 (https=) | ||
| US11970480B2 (en) | Heterocyclic amides useful as protein modulators | |
| US11377440B2 (en) | Modulators of stimulator of interferon genes (STING) | |
| JP2019523633A5 (https=) | ||
| AU2018344902B2 (en) | Modulators of stimulator of interferon genes (STING) useful in treating HIV | |
| ES2781474T3 (es) | Amidas heterocíclicas útiles como moduladores de proteínas | |
| ES2387584T3 (es) | Derivados ésteres y amidas de indazolilo para el tratamiento de trastornos mediados por el receptor de glucocorticoides | |
| US8841311B2 (en) | Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments | |
| EA201992126A1 (ru) | Ингибиторы jak, содержащие 4-членный гетероциклический амид | |
| HUE032868T2 (en) | 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group | |
| CA2884922C (en) | N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists | |
| ES2636864T3 (es) | Preparación de intermedios de pirimidina útiles para la fabricación de macitentán | |
| EP3563851B1 (en) | Antitumor agent and bromodomain inhibitor | |
| RS55012B1 (sr) | 5-[(3,3,3-trifluoro-2-hidroksi-1-arilpropil)amino]-1h-hinolin-2-on, procesi za njihovu proizvodnju i njihova upotreba kao anti-upalni agensi | |
| AU2020313374B2 (en) | Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of STING | |
| CA3164751A1 (en) | Compounds | |
| Kaur et al. | Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system | |
| CN107207468A (zh) | 吡嗪甲酰胺化合物的制造方法及其合成中间体 | |
| CN115477639B (zh) | 一种以fgfr1为靶点的多取代嘧啶类化合物及其制备方法和用途 | |
| CA3147538A1 (en) | Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting | |
| Stroganova et al. | 3-Aminofuro [2, 3-b] pyridines: Reaction with N-chlorosuccinimide and sodium hypochlorite | |
| WO2015113192A1 (zh) | 苯并内酰胺化合物及其合成方法和应用 | |
| US12617780B2 (en) | Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting | |
| NZ594217A (en) | Novel saponin compounds, methods of preparation thereof, use thereof and pharmaceutical compositions | |
| WO2023126978A1 (en) | Process to prepare octopamine sulfate |